Atria Investments’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Buy
15,568
+34
+0.2% +$788 ﹤0.01% 1647
2026
Q1
$320K Sell
15,534
-4,287
-22% -$96.6K ﹤0.01% 1719
2025
Q4
$470K Buy
19,821
+2,159
+12% +$52.6K 0.01% 1490
2025
Q3
$440K Buy
17,662
+386
+2% +$8.31K 0.01% 1495
2025
Q2
$397K Buy
17,276
+1,033
+6% +$23.9K ﹤0.01% 1547
2025
Q1
$365K Buy
16,243
+2,229
+16% +$51.8K ﹤0.01% 1510
2024
Q4
$274K Buy
14,014
+1,494
+12% +$29.6K ﹤0.01% 1637
2024
Q3
$228K Buy
12,520
+490
+4% +$9.35K ﹤0.01% 1761
2024
Q2
$209K Buy
+12,030
New +$213K ﹤0.01% 1801

Other funds holding PRVA

Atria Investments's PRVA Position: Q2 2026 in Review

Atria Investments increased its Privia Health (PRVA) stake by 0.22% in Q2 2026, buying an estimated $788 and bringing the position to 15,568 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Atria Investments first reported a position in PRVA in Q2 2024 and has held it in 9 quarters since. The position peaked at $470K in Q4 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Atria Investments held 15,568 shares of Privia Health worth $401K as of Q2 2026.
  • Atria Investments bought 34 Privia Health shares in Q2 2026, an estimated $788.
  • Privia Health made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1647 holding.
  • Atria Investments first reported a position in Privia Health in Q2 2024 and has held it in 9 quarters since.
  • Atria Investments's Privia Health position peaked at $470K in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.